Duke Urologic Assembly
In Response to COVID-19
Officials at Duke, along with health officials worldwide, are actively monitoring the local and global health status of the novel coronavirus that causes the COVID-19 disease:
Large events and mass gatherings can contribute to the spread of COVID-19 in the United States via travelers who attend these events and introduce the virus to new communities.
In support of this effort to mitigate the spread of the coronavirus and in consideration for the well-being of our external faculty, Duke is postponing, cancelling or virtualizing any Duke-sponsored in-person event taking place on-campus or off-campus until further notice.
This includes recruitment events, tours, student programs, reunions, performances, conferences and social events. For more information on Duke's response, please see coronavirus.duke.edu/events
2021 LEADING EDGE UROLOGY: Duke Urologic Assembly and Urologic Cancer Symposium
April 8 - April 11, 2021
Please check back for updates or contact email@example.com with questions
2020 LEADING EDGE UROLOGY: 52nd Duke Urologic Assembly & Urologic Cancer Symposium Cancelled
UPDATE March 11, 2020
The Planning Committee, led by Andrew J. Armstrong, MD, Michael N. Ferrandino, MD, Glenn M. Preminger, MD, in collaboration with the Duke Office of Continuing Medical Education has made the difficult, but necessary decision to cancel the 2020 DUA to support efforts to contain and mitigate against threats posed by the coronavirus outbreak. We wish to sincerely thank you for your patience and understanding as we evaluated postponement and cancellation options. In response to these unprecedented circumstances, our leadership is adjusting the cancellation policy for this event. Please also allow us time to process full registration fee refunds for the registrants. Information for exhibitors and sponsors will be forthcoming.
MARCH 26 - 29, 2020
Hilton Head, SC
2020 Duke Urologic Assembly & Urologic Cancer Symposium AGENDA (Cancelled)
Join an outstanding roster of national urologists, oncologists, and radiologists participating in a comprehensive scientific program that encompasses leading edge updates on the most effective and efficient diagnoses and treatments in the sub-specialties of urology.
The rapid evolution of knowledge coupled with an unprecedented release of practice changing clinical trials require an ongoing review to ensure accurate diagnosis and disease management options by all levels of the urologic community.
Healthcare professionals attending this symposium will be engaged through interactive talks, supplemented with video surgical presentations, interactive case presentations, and panel discussions on the latest evidence-based clinical approaches to managing a wide range of urologic conditions.
After attending this program, participants should be able to:
•Apply effective and efficient diagnosis and treatments in the sub-specialties of urology and urologic oncology
•Analyze new technologies and therapies to provide the utmost, least invasive care to patients
•Evaluate and outline management options for the various urologic conditions
•Choose appropriate patients for minimally invasive surgical approaches
•Distinguish various surgical approaches and compare their effectiveness and safety profiles
•Develop collaboration between urologists, genitourinary oncologists, and radiation oncologists for patient care from diagnosis to management
In support of improving patient care, the Duke University Health System Department of Clinical Education and Professional Development is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.